The Breast · 2016 · 123 citations · 18 references
MedicineOncologyPathologyBreast OncologySurgical OncologyTumor PathologyBreast Cancer OncologyBreast Cancer RecurrenceBreast PathologyMolecular Classification Of TumorsTumor CharacterizationTumor ClassificationBreast Cancer PrognosisBreast Tumor ClassificationClassification SurrogatesClinicopathologic FeaturesDisease Subtype ClassificationDisease-free Survival AnalysisNodal Involvement AssessmentRecurrence
AIMS: To evaluate how the St. Gallen intrinsic subtype classification for breast cancer surrogates predicts disease features, recurrence patterns and disease free survival. MATERIALS AND METHODS: Subtypes were classified by immunohistochemical staining according to St. Gallen subtypes classification in a 5-tyre system: luminal A, luminal B HER2-neu negative, luminal B HER2-neu positive, HER2-neu non luminal or basal-like. Data were obtained from the records of patients with invasive breast cancer treated at our institution. Recurrence data and site of first recurrence were recorded. The chi(2) test, analysis of variance, and multivariate logistic regression analysis were used to determine associations between surrogates and clinicopathologic variables. RESULTS: A total of 2.984 tumors were classifiable into surrogate subtypes. Significant differences in age, tumor size, nodal involvement, nuclear grade, multicentric/multifocal disease (MF/MC), lymphovascular invasion, and extensive intraductal component (EIC) were observed among surrogates (p < 0.0001). After adjusting for confounding factors surrogates remained predictive of nodal involvement (luminal B HER2-neu pos. OR = 1.49 p = 0.009, non-luminal HER2-neu pos. OR = 1.61 p = 0.015 and basal-like OR = 0.60, p = 0.002) while HER2-neu positivity remained predictive of EIC (OR = 3.10, p < 0.0001) and MF/MC (OR = 1.45, p = 0.02). Recurrence rates differed among the surrogates and were time-dependent (p = 0.001) and site-specific (p < 0.0001). CONCLUSION: The St. Gallen 5-tyre surrogate classification for breast cancer subtypes accurately predicts breast cancer presenting features (with emphasis on prediction of nodal involvement), recurrence patterns and disease free survival.
18
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Lisa A. Carey, Charles M. Perou, Chad Livasy et al. · JAMA · 2006 · 3.8K citations
Medicine, Biostatistics, Oncology +14
Metastatic Behavior of Breast Cancer Subtypes
Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Alan S. Coates, Eric P. Winer, Aron Goldhirsch et al. · Annals of Oncology · 2015 · 1.8K citations · Full text
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc, Maggie C.U. Cheang, Scott Tyldesley et al. · Journal of Clinical Oncology · 2010 · 1.2K citations
Medicine, Cancer Biology, Oncology +14